作者：
Gloria B,Kim [1]
;
Jens,Fritsche [2]
;
Sebastian,Bunk [2]
;
Andrea,Mahr [2]
;
Felix,Unverdorben [2]
;
Kevin,Tosh [1]
;
Hong,Kong [1]
;
Colby R,Maldini [1]
;
Chui,Lau [1]
;
Sriram,Srivatsa [1]
;
Shuguang,Jiang [1]
;
Joshua,Glover [1]
;
Derek,Dopkin [1]
;
Carolyn X,Zhang [1]
;
Heiko,Schuster [2]
;
Daniel J,Kowalewski [2]
;
Valentina,Goldfinger [2]
;
Martina,Ott [2]
;
David,Fuhrmann [2]
;
Maike,Baues [2]
;
Hans,Boesmueller [3]
;
Christoph,Schraeder [2]
;
Gisela,Schimmack [2]
;
Colette,Song [2]
;
Franziska,Hoffgaard [2]
;
Michael,Roemer [2]
;
Chih-Chiang,Tsou [4]
;
Martin,Hofmann [2]
;
Thomas,Treiber [2]
;
Meike,Hutt [2]
;
Leonie,Alten [2]
;
Maike,Jaworski [2]
;
Amir,Alpert [4]
;
Sarah,Missel [2]
;
Carsten,Reinhardt [2]
;
Harpreet,Singh [2]
;
Oliver,Schoor [4]
;
Steffen,Walter [2]
;
Claudia,Wagner [4]
;
Dominik,Maurer [2]
;
Toni,Weinschenk [2]
;
James L,Riley [2]
作者单位：
Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
[1]
Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
[2]
Institute of Pathology and Neuropathology, Eberhard Karls University, 72076 Tuebingen, Germany.
[3]
Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA.
[4]
主题词
抗原, 肿瘤(Antigens, Neoplasm);细胞系, 肿瘤(Cell Line, Tumor);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);蛋白质组学(Proteomics);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);T淋巴细胞(T-Lymphocytes)
DOI
10.1126/scitranslmed.abo6135
PMID
36044599
发布时间
2023-04-28
换一批
换一批
